- •Thrombectomy has not been proven to reduce mortality in stroke patients.
- •Age, NIHSS score, and successful revascularization were predictors of mortality.
- •Further efforts to identify modifiable risk factors of mortality are warranted.
The aims of this single-center, retrospective cohort study are to assess the outcomes of endovascular mechanical thrombectomy (EMT) for acute ischemic stroke (AIS) and determine predictors of 30-day mortality at an academic comprehensive stroke center (CSC).
We retrospectively collected data from consecutive patients who underwent EMT for AIS at our institution between April 2016 and January 2018. Primary outcome was defined as mortality within 30 days from EMT. Successful revascularization was defined as a modified Thrombolysis in Cerebral Infarction (mTICI) grade 2b-3. Statistical analyses were performed to identify predictors of 30-day mortality.
The study cohort was comprised 57 patients (51% male) with mean age of 72 years. Intravenous tissue plasminogen activator was administered in 51%. The median Alberta Stroke Program Early Computed Tomography Score (ASPECTS) and National Institutes of Health Stroke Scale (NIHSS) score were 8 and 20, respectively. The 30-day mortality rate was 39%. Univariate analyses found that older age (mean 77 vs. 68 years, p = 0.022), higher baseline NIHSS score (median 23 vs. 19, p = 0.032), NIHSS score at 24 h after EMT (median 14.5 vs. 7.5, p < 0.001), and lower rates of successful revascularization (59% vs. 89%, p = 0.021) were associated with 30-day mortality.
We observed a moderate rate of 30-day mortality after EMT at an academic CSC. Older age, higher baseline NIHSS score, higher NIHSS score at 24 h after thrombectomy, and lower rates of successful revascularization were predictive of 30-day mortality in univariate analysis. Further efforts to identify modifiable risk factors of mortality are warranted.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Clinical Neuroscience
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Endovascular vs medical management of acute ischemic stroke.Neurology. 2015; 85: 1980-1990
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.Lancet (London, England). 2016; 387: 1723-1731
- Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.Lancet Neurol. 2016; 15: 1138-1147
- Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial.JAMA. 2017; 318: 443-452
- Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging.N Engl J Med. 2018; 378: 708-718
- Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct.N Engl J Med. 2018; 378: 11-21
- Predictive factors for good outcome and mortality after stent-retriever thrombectomy in patients with acute anterior circulation stroke.J Stroke. 2017; 19: 97-103
- Predictors for mortality after mechanical thrombectomy of acute basilar artery occlusion.Cerebrovasc Dis (Basel, Switzerland). 2018; 45: 61-67
- Predictors of mortality in acute ischemic stroke intervention: analysis of the north american solitaire acute stroke registry.Stroke. 2015; 46: 2305-2308
- Influence of age on clinical and revascularization outcomes in the North American Solitaire Stent-Retriever Acute Stroke Registry.Stroke. 2014; 45: 3631-3636
- 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2018; 49: e46-e110
- Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy ASPECTS Study Group. Alberta Stroke Programme Early CT Score.Lancet (London, England). 2000; 355: 1670-1674
- Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.Stroke. 2013; 44: 2650-2663
- Comparative safety and efficacy of combined IVT and MT with direct MT in large vessel occlusion.Neurology. 2018;
- Mechanical thrombectomy outcomes with and without intravenous thrombolysis in stroke patients: a meta-analysis.Stroke. 2017; 48: 2450-2456
- Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke: primary results of the STRATIS registry.Stroke. 2017; 48: 2760-2768
- Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial.Lancet (London, England). 2012; 380: 1231-1240
- Transfer to high-volume centers associated with reduced mortality after endovascular treatment of acute stroke.Stroke. 2017; 48: 1316-1321
Published online: August 22, 2018
Accepted: August 13, 2018
Received: April 28, 2018
© 2018 Elsevier Ltd. All rights reserved.